by Dr. Alyssa Master | Aug 24, 2020
The surge of cellular T cell-based immunotherapies has prompted more and more researchers to take an interest in these specialized immune cells. Whether you are brand new to the cell therapy field or an experienced immunologist, learning to work with a new cell type...
![Top 10 Cell Therapy Conferences for 2020 [UPDATED]](https://nucleusbiologics.com/wp-content/uploads/2020/07/newbannerconferencesimage-1.png)
by Dr. Alyssa Master | Jul 8, 2020
While COVID-19 may have prevented many planned cell therapy conferences from meeting in-person, a great many have become virtual, and some are still planning to go on in-person. Here are 10 conferences we want to attend this year, from July to November. Don’t miss...
![Kymriah vs. Yescarta [UPDATED]](https://nucleusbiologics.com/wp-content/uploads/2019/05/kymriah-vs-yescarta-feat.jpg)
by Dr. Alyssa Master | Aug 20, 2019
Kymriah® and Yescarta® are currently the only two FDA-approved CAR-T cell therapy products available on the market in the United States. Do you have trouble distinguishing between them? We created a simple chart to showcase some of the similarities and differences...
by Dr. Alyssa Master | Aug 5, 2019
Nucleus Biologics™ now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – August 6, 2019 – Nucleus Biologics™, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition...
by Ashley Fallon | Jul 16, 2019
Islet cell transplantation is an experimental treatment for Type 1 diabetes. Islet cells are responsible for producing and secreting insulin. Without proper islet cell function, a patient becomes dependent on insulin injections. To alleviate this dependency, islet...
